![Invitrogen™ GeneArt™ Platinum™ Cas9 Nuclease (1 µg/µL) 25 μg Direct PCR Reagents and Kits | Fisher Scientific Invitrogen™ GeneArt™ Platinum™ Cas9 Nuclease (1 µg/µL) 25 μg Direct PCR Reagents and Kits | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/product-images/B25640-10in.jpg-650.jpg)
Invitrogen™ GeneArt™ Platinum™ Cas9 Nuclease (1 µg/µL) 25 μg Direct PCR Reagents and Kits | Fisher Scientific
![The GeneArt® CRISPR Nuclease mRNA system with in vitro transcribed gRNA produces high genome-editing efficiency in iPSCs | Thermo Fisher Scientific - ES The GeneArt® CRISPR Nuclease mRNA system with in vitro transcribed gRNA produces high genome-editing efficiency in iPSCs | Thermo Fisher Scientific - ES](https://tools.thermofisher.com/content/sfs/gallery/low/CRISPR-mRNA-Fig6.jpg)
The GeneArt® CRISPR Nuclease mRNA system with in vitro transcribed gRNA produces high genome-editing efficiency in iPSCs | Thermo Fisher Scientific - ES
![Nutrients | Free Full-Text | Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias Nutrients | Free Full-Text | Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias](https://pub.mdpi-res.com/nutrients/nutrients-15-00505/article_deploy/html/images/nutrients-15-00505-g001.png?1675388942)
Nutrients | Free Full-Text | Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias
![Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients: Molecular Therapy - Nucleic Acids Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/47d9127a-2d5b-4490-9e3b-6f801474354f/fx1_lrg.jpg)
Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients: Molecular Therapy - Nucleic Acids
![IJMS | Free Full-Text | High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs IJMS | Free Full-Text | High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs](https://pub.mdpi-res.com/ijms/ijms-24-03655/article_deploy/html/images/ijms-24-03655-g001.png?1676364235)